Horizon CDT Year 1
Horizon CDT Year 1
批准号:
2887466
负责人:
金额:
$0.0万
依托单位:
依托单位国家:
英国
项目类别:
Studentship
财政年份:
2023
资助国家:
英国
项目状态:
未结题
起止时间:
2023 至 --
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Rider Spoke is a project that invites you to cycle alone through the city with a smartphone attached to your handlebars. Guided by the voice of a narrator, you are asked questions about your life and then search for a place to record your answer to each one. As you cycle, you choose whether to answer another question or listen to the answers left by other cyclists.Conceived by Blast Theory in 2007 as a response to the emergence of user-generated content, the project facilitates contributions from its audiences that are open, intimate and reflective. After taking part, audiences commonly report a feeling of recognition in the recordings they listen to, and a renewed sense of belonging to the city and its people.The project has toured to 30 cities around the world with about twenty-five thousand audience recordings being made in that time. As such, it offers a unique opportunity to study how sharing personal stories can contribute to social cohesion and explore the potential that machine learning and large language models might play in this context.What new insights about the stories shared within Rider Spoke can these technologies produce? And how might these technologies be used by artists and designers of mixed reality experiences to support social cohesion?I will combine linguistic and machine learning approaches to study the stories and data saved in Rider Spoke recordings. And - informed by insights from this study - I will design a series of novel public prototypes that test potential roles for AI in supporting social cohesion on new platforms, and in new contexts.This author is supported by the Horizon Centre for Doctoral Training at the University of Nottingham (UKRI Grant No. EP/S023305/1).
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
国内基金
海外基金
登录
查看更多内容
燕麦蒽酰胺-CDT协同益生菌介导PD-1阻断抗乳腺癌机制研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:毛慧佳
-
依托单位:
基于纳米酶分子成像与酶级联增效CDT/PTT/免疫协同治疗乳腺癌的
实验研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2024
-
负责人:卢岷
-
依托单位:
Ti3C2@Chitosan-MnFe2O4改良型胆管支架经PTT/CDT协同作用治疗胆道恶性梗阻的应用研究
-
批准号:82303708
-
项目类别:青年科学基金项目
-
资助金额:30万元
-
批准年份:2023
-
负责人:熊文芳
-
依托单位:
三重增强Fenton催化效应介导CDT药物载体构筑及抑瘤机制研究
-
批准号:32260237
-
项目类别:地区科学基金项目
-
资助金额:32万元
-
批准年份:2022
-
负责人:李景华
-
依托单位:
肿瘤微环境响应铁基纳米金属有机框架增强PDT-CDT协同并联合PD-1抗肿瘤治疗及机制研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:10.0万元
-
批准年份:2022
-
负责人:徐清波
-
依托单位:
自供O2/H2O2的复合递送系统联合CDT疗法促进感染性皮肤修复及机制研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2021
-
负责人:陶白龙
-
依托单位:
CDT1单核苷酸多态性影响肝细胞癌基因组稳定性的机制探索研究
-
批准号:82160466
-
项目类别:地区科学基金项目
-
资助金额:35万元
-
批准年份:2021
-
负责人:王志鑫
-
依托单位:
DNA复制许可因子Cdt1促进中心体扩增诱导肺癌PGCC形成的机制研究
-
批准号:82173365
-
项目类别:面上项目
-
资助金额:55万元
-
批准年份:2021
-
负责人:王耀春
-
依托单位:
CDT2介导CDKs活化促进APP异常剪切参与AD发病机理研究
-
批准号:32000688
-
项目类别:青年科学基金项目
-
资助金额:24.0万元
-
批准年份:2020
-
负责人:黄芳
-
依托单位:
CDT2介导Aβ毒性参与阿尔茨海默症的分子机制研究
-
批准号:--
-
项目类别:海外学者研究基金项目
-
资助金额:160万元
-
批准年份:2019
-
负责人:张斌
-
依托单位: